Designing nanocarriers to overcome the limitations in conventional drug administration for Parkinson’s disease

Detalles Bibliográficos
Autores principales: García-Muñoz, Rafael A., McConnell, Joseph, Morales, Victoria, Sanz, Raul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820718/
https://www.ncbi.nlm.nih.gov/pubmed/35017428
http://dx.doi.org/10.4103/1673-5374.332143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820718/
https://www.ncbi.nlm.nih.gov/pubmed/35017428
http://dx.doi.org/10.4103/1673-5374.332143

Ejemplares similares